Table 4.

Gene signature predictive of overall for patients with MI tumors(stage T2–T4).

Gene Symbol	Probeset	Gene Name
APOBEC3B	206632_s_at	apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B
ATF3	202672_s_at	activating transcription factor 3
CCL5	204655_at	chemokine (C-C motif) ligand 5
DGCR2	214198_s_at	DiGeorge syndrome critical region gene 2
ENDOD1	212573_at	endonuclease domain containing 1
FADD	202535_at	Fas (TNFRSF6)-associated via death domain
JUNB	203022_at	ribonuclease H2, subunit A
LMO7	242722_at	LIM domain 7
MAP2K1	202670_at	mitogen-activated protein kinase kinase 1
MAP3K1	225927_at	mitogen-activated protein kinase kinase kinase 1
PDGFC	218718_at	platelet derived growth factor C
PEA15	200787_s_at	phosphoprotein enriched in astrocytes 15
PFN1	214617_at	perforin 1 (pore forming protein)
PPP1R12A	201604_s_at	protein phosphatase 1, regulatory (inhibitor) subunit 12A
PRDX1	208680_at	peroxiredoxin 1
PRMT1	206445_s_at	protein arginine methyltransferase 1
SLC1A5	208916_at	solute carrier family 1 (neutral amino acid transporter), member 5
TNFAIP6	206025_s_at	tumor necrosis factor, alpha-induced protein 6
TSG101	201758_at	tumor susceptibility gene 101
TSPAN5	209890_at	tetraspanin 5